Display options
Share it on

Evid Based Complement Alternat Med. 2011;2011:315858. doi: 10.1155/2011/315858. Epub 2011 Apr 11.

Cattle bile aggravates diclofenac sodium-induced small intestinal injury in mice.

Evidence-based complementary and alternative medicine : eCAM

Hironori Ishikawa, Shiro Watanabe

Affiliations

  1. Division of Clinical Application, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

PMID: 21584236 PMCID: PMC3092561 DOI: 10.1155/2011/315858

Abstract

Cattle bile (CB) has long been used in Japan as an ingredient of digestive medicines. Bile acids are major chemical constituents of CB, and CB ingestion is assumed to affect small intestinal injury induced by nonsteroidal anti-inflammatory drugs (NSAIDs). Mice were fed a diet supplemented with or without CB for 7 days and treated with diclofenac sodium (DIF) to induce small intestinal injury. Lesion formation was enhanced, and PGE2 content and COX expression levels were elevated in the small intestine of DIF-treated mice fed the CB diet compared with those fed the control diet. The administration of a reconstituted mixture of bile acids found in CB enhanced lesion formation in DIF-treated mice. CB administration elevated the contents of CB-derived bile acids in the small intestine, some of which exhibited a high cytotoxicity to cultured intestinal epithelial cells. These results suggest that the elevated levels of CB-derived cytotoxic bile acids in the small intestine contribute to the aggravation of DIF-induced small intestinal injury. The use of CB may be limited during the therapy of inflammatory diseases with NSAIDs.

References

  1. J Pediatr Gastroenterol Nutr. 2001 Mar;32(3):270-3 - PubMed
  2. Postgrad Med J. 2006 Mar;82(965):186-91 - PubMed
  3. J Lab Clin Med. 1992 Aug;120(2):329-41 - PubMed
  4. Nat Med. 1995 Feb;1(2):154-8 - PubMed
  5. Clin Chim Acta. 2010 Apr 2;411(7-8):459-66 - PubMed
  6. Pharmacology. 1985;30(1):32-9 - PubMed
  7. Lancet. 1987 Sep 26;2(8561):711-4 - PubMed
  8. Am J Physiol. 1997 May;272(5 Pt 1):G1249-57 - PubMed
  9. Arthritis Rheum. 1996 Feb;39(2):321-4 - PubMed
  10. Biol Pharm Bull. 2006 Jul;29(7):1319-24 - PubMed
  11. J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 2):e384-9 - PubMed
  12. Dig Liver Dis. 2000 Nov;32(8):691-8 - PubMed
  13. Gastroenterology. 1991 Aug;101(2):457-64 - PubMed
  14. J Lipid Res. 2007 Jan;48(1):242-51 - PubMed
  15. Anal Biochem. 2001 Nov 15;298(2):293-8 - PubMed
  16. Dig Dis Sci. 2006 Apr;51(4):766-74 - PubMed
  17. Gastroenterology. 2004 Mar;126(3):724-31 - PubMed
  18. Gastroenterology. 1998 Dec;115(6):1476-82 - PubMed
  19. Br J Pharmacol. 2008 Mar;153(5):1072-84 - PubMed
  20. Hepatology. 2001 Nov;34(5):868-76 - PubMed
  21. Arch Toxicol. 2007 Apr;81(4):291-8 - PubMed
  22. Gastroenterology. 2005 May;128(5):1172-8 - PubMed
  23. Eur J Pharmacol. 2000 Feb 4;388(3):281-5 - PubMed
  24. Transl Res. 2006 Jul;148(1):37-45 - PubMed
  25. J Lipid Res. 1989 May;30(5):719-30 - PubMed
  26. Clin Biochem. 2007 May;40(8):503-10 - PubMed
  27. Gen Pharmacol. 1995 Nov;26(7):1455-9 - PubMed
  28. J Ethnopharmacol. 2009 Sep 7;125(2):203-6 - PubMed

Publication Types